Science & Co Tirzepatide Review: $199 a Month, $125 Only on a Year (2026)

Science & Co advertises compounded tirzepatide at "PLANS AS LOW AS $125 /month" against a struck-through $199, with "Save 37%" beside it. Read the FAQ on the same page and the company explains its own asterisk: "Plans start at $125 a month on the 12 month plan, which works out at about $4 a day."¹ So $199 is the per-month rate and $125 is a year's commitment. Read live on 13 September 2026.

The arithmetic backs the company up

This matters because a struck-through number is usually where this field invents something. Here it does not: 125 ÷ 199 = 63%, which is exactly the "Save 37%" printed on the page. The reference price is internally consistent with the discount claimed against it, and the FAQ names the commitment behind the low figure in plain words. That is a materially better disclosure than an unexplained anchor like Renlo Health's $399 — even though Renlo's actual headline is the more honest of the two.

The sentence most programs we review never print

In its footer, twice: "Science and Co, Inc. is not a 503A or 503B compounding facility." Most programs we review never raise the question of what they are, and a reader is left to assume the brand on the website is the outfit making the drug. Science & Co says outright that it is not, and describes the arrangement instead: a state-licensed U.S. compounding pharmacy prepares the medication, with every batch described as third-party tested for purity and potency, and compounding pharmacies described as licensed and inspected by state boards of pharmacy.

What it does not do is name that pharmacy. Declaring what you are not is a real disclosure; it is not the same as No BS RX publishing four dispensing addresses and phone numbers.

What is in the price

"Same Price, Any Dose" is stated on the product page, and the FAQ adds "no hidden fees, no monthly membership, and free shipping on every order." The company names itself and its state of incorporation — Science and Co, Inc., a Delaware corporation — and publishes a telephone number. Free delivery and 24/7 care-team messaging are stated in the how-it-works steps.

What the page leaves out

Only two figures are published: the twelve-month rate and the reference rate. What a three- or six-month plan costs is not on the page, so a reader who wants a middle rung has to start an intake to find one. Compare Idgie Health or Edessa, both of which print every rung with the amount billed today.

Science & Co also lists Ozempic, Wegovy, Zepbound and a GLP-1/GIP microdose under its weight-loss menu, none of them priced on the tirzepatide page.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound or Mounjaro, and the page says so itself: "Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA." Our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands.

Does the drug work? (Separate from the provider)

Pricing is the seller's problem; efficacy is the molecule's. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks², and SURMOUNT-5 placed it ahead of semaglutide head to head³, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

The honest verdict

Budget for $199 a month unless you are willing to commit to a full year, in which case $125 is real and the company says so where you can find it. The compounding disclosure is genuinely better than this field's norm and the missing middle rungs are genuinely worse. If you want the pharmacy named as well as the arrangement described, No BS RX publishes four of them; if you want a rate that needs no commitment at all, Renlo Health bills $269 monthly and locks the dose price. The ranked best tirzepatide providers list sets them against the field.